8 GHP International Life Sciences Awards 2024 ince 2006, NewEast Biosciences has been a leader in its niche of biological research, creating antibodies which identify active G proteins, providing an extraordinarily useful tool to research signal transduction. Protein production also benefits from the company’s market-leading protein expression services. The company’s antibody production services include monoclonal and polyclonal antibodies. The monoclonal variety are produced by hybridoma cells, achieved via fusion technology, and these bind to specific antigen epitopes. They are able to identify specific proteins, have a range of highly targeted applications, and boast the higher specificity of the two types by a wide margin with lower betweenbatch variability. They produce identical antibodies and therefore have use cases such as in therapeutic drug development. “We use antibody affinity purification to ensure high antibody purity. Whether you use it downstream for diagnostic testing or drug research, its effectiveness is guaranteed.” Custom polyclonal antibodies are available using a wider choice of host animals, take less time to produce, and are applicable to their own range of contexts. NewEast provides offers customers a complete set of solutions from target design, antigen preparation to production, and purification and quality testing to ensure the antibodies’ effectiveness in project research. NewEast’s contribution to the protein research space extends beyond antibody production, however, extending to protein services using E. coli, mammalian cell, and yeast protein expression systems. Its E. coli protein service is an easy operation, low-cost, high expression service, providing a success rate up to 95%. Jun24217 S GTPases are a family of hydrolase enzymes which play roles in the regulation of cell growth, cell differentiation, maintaining cell pressure, calcium regulation and more. They are one of the many seemingly minute yet vital elements of human biology that work to support day-to-day function. NewEast Biosciences is a pioneer in the field of GTPase research and is a cuttingedge presence in antibody productions and protein expression. “With our rich experience, we offer multiple fusion/affinity tags to increase the protein solubility, expression levels, and ease of purification.” As experts in CHO and HEK293 cell expression, NewEast provides a mature mammalian protein expression service, available, for instance, for use in the development and production of therapeutic recombinant monoclonal antibody drugs and protein drugs. This process provides quality protein with a high rate of success. NewEast also offers yeast protein expression services, the most economical and efficient among eukaryotic protein expression systems. With a high activity rate, fast growth rate, low culture cost, and clear genetic background, it proves an effective, rapid solution for expression. As well as conducting leading research and development, the company also provides lab equipment and assay kits, filters, centrifuge tubes, and a host of other products. Its proteins, antibodies, and biological goods are applicable to numerous areas of research, including cancer, immunology, signal transduction, neuroscience, and more. Not only has NewEast Biosciences broken new ground since its conception, but it has also fostered effective research across the whole scientific community and continues to do so. Contact: Don Wu Company: NewEast Biosciences LLC Web Address: www.neweastbio.com Most Innovative GTPase & Oncogene Antibody R&D Firm 2024
RkJQdWJsaXNoZXIy MTUyMDQwMA==